Brendel Financial Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-11,888
Closed -$1.49M 112
2021
Q3
$1.49M Buy
+11,888
New +$1.54M 1.78% 24
2020
Q2
Sell
-5,129
Closed -$463K 87
2020
Q1
$463K Sell
5,129
-3
-0.1% -$319 0.55% 47
2019
Q4
$582K Buy
5,132
+1,749
+52% +$192K 0.49% 52
2019
Q3
$367K Buy
+3,383
New +$353K 0.33% 65

Other funds holding MDT

Brendel Financial Advisors's MDT Position: Q4 2021 in Review

Brendel Financial Advisors sold out of Medtronic (MDT) in Q4 2021, closing a stake of 11,888 shares — an estimated $1.49M sold.

Brendel Financial Advisors first reported a position in MDT in Q3 2019 and held it in 4 quarters. The position peaked at $1.49M in Q3 2021. 2,060 funds tracked by Wall St. Rank hold MDT as of Q4 2021.

  • Brendel Financial Advisors reported no remaining Medtronic position as of Q4 2021 after selling out during the quarter.
  • Brendel Financial Advisors sold 11,888 Medtronic shares in Q4 2021, an estimated $1.49M.
  • Brendel Financial Advisors first reported a position in Medtronic in Q3 2019 and held it in 4 quarters.
  • Brendel Financial Advisors's Medtronic position peaked at $1.49M in Q3 2021.
  • 2,060 funds tracked by Wall St. Rank held Medtronic as of Q4 2021.

Based on Brendel Financial Advisors's 13F filing for Q4 2021, filed 10 Feb 2022.